Medtronic’s Affera Sphere-9 Catheter shows promising results for atrial fibrillation treatment
Medtronic plc (NYSE: MDT), a leader in healthcare technology, announced breakthrough results at the Heart Rhythm Society (HRS) 2024 Annual Meeting for its Affera Mapping ... Read More
Viz.ai, Bristol Myers Squibb sign deal for AI algorithm and Viz HCM software
Viz.ai, an artificial intelligence (AI) powered health technology company, has signed a multi-year agreement with Bristol Myers Squibb (BMY) to provide the latter with an ... Read More
Zydus Lifesciences bags FDA final approval for Apixaban Tablets
Zydus Lifesciences has bagged final approval from the US Food and Drug Administration (FDA) for Apixaban Tablets, 2.5mg and 5mg, a generic version of Eliquis ... Read More
US medical device company Adagio Medical raises $42.5m in Series E
Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a ... Read More
CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF
Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More
Micro Labs, Mylan secure FDA approval for first generics of Eliquis
Micro Labs and Mylan Pharmaceuticals have secured approval from the US Food and Drug Administration (FDA) for two applications for the first generics of Eliquis ... Read More
FDA rejects Correvio Pharma’s anti-arrhythmic drug Brinavess
Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug Brinavess (vernakalant IV). In this connection, the ... Read More
Boston Scientific’s LUMINIZE RF Balloon Catheter shows promising results in AF-FICIENT I trial
Boston Scientific has announced that its LUMINIZE Radiofrequency (RF) Balloon Catheter, developed for isolating pulmonary veins (PVs) in atrial fibrillation (AF) treatment, has demonstrated positive ... Read More